This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Zhengchao Tu: Innovator in Heterocyclic Urea Compounds
Introduction
Zhengchao Tu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug compositions. His work focuses on addressing critical challenges in immunological therapy.
Latest Patents
Zhengchao Tu holds a patent for a heterocyclic urea compound, specifically an indoleamine-2,3-dioxygenase inhibitor. This invention aims to solve the issues of weak curative effects and the larger toxic and side effects associated with existing immunological therapy drugs. The patent also includes a preparation method for this inhibitor and its application in creating drugs for treating or preventing tumors. He has 1 patent to his name.
Career Highlights
Zhengchao Tu is affiliated with China Pharmaceutical University, where he continues to advance research in pharmaceutical sciences. His work has garnered attention for its potential impact on cancer treatment and immunotherapy.
Collaborations
Zhengchao Tu collaborates with esteemed colleagues, including Yatao Qiu and Sheng Jiang. Their combined expertise contributes to the advancement of innovative solutions in the pharmaceutical field.
Conclusion
Zhengchao Tu's contributions to the development of heterocyclic urea compounds represent a significant step forward in the fight against tumors. His innovative approach and dedication to research continue to inspire advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile